Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sinusitis Hevert SL in acute uncomplicated rhinosinusitis
2014-000907-29Phase 4Completed
- Sponsor
- Hevert-Arzneimittel
- Start
- Jul 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute rhinosinusitis (ARS) comparing Sinusitis Hevert SL with Placebo (2 arms). Primary endpoint: Responder rate based on MRSSpat. Started Jul 2014; status: completed.
02
Drugs
Sinusitis Hevert SL
03
Conditions
acute rhinosinusitis (ARS)
Beyond the preview
Go deeper on 2014-000907-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000907-29.